Literature DB >> 30237836

Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study.

Yazid N Al Harmarneh1,2,3,4,5, Sarah Lamb1,2,3,4,5, Maoliosa Donald1,2,3,4,5, Brenda Hemmelgarn1,2,3,4,5, Kathryn King Shier1,2,3,4,5, Charlotte A Jones1,2,3,4,5, Cliff Mitchell1,2,3,4,5, Ross T Tsuyuki1,2,3,4,5.   

Abstract

Entities:  

Year:  2018        PMID： 30237836      PMCID： PMC6141945          DOI： 10.1177/1715163518779092

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  14 in total

1.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

2.  Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

Authors:  Maoliosa Donald; Kathryn King-Shier; Ross T Tsuyuki; Yazid N Al Hamarneh; Charlotte A Jones; Braden Manns; Marcello Tonelli; Wendy Tink; Nairne Scott-Douglas; Brenda R Hemmelgarn
Journal:  CMAJ Open       Date:  2017-03-06

3.  Expanded pharmacy practice: Where are we, and where do we need to go?

Authors:  Jeff Morrison
Journal:  Can Pharm J (Ott)       Date:  2013-11

4.  Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.

Authors:  Beata V Bajorek; Kate S LeMay; Parker J Magin; Christopher Roberts; Ines Krass; Carol L Armour
Journal:  Int J Pharm Pract       Date:  2016-09-16

5.  The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.

Authors:  Ross T Tsuyuki; Yazid N Al Hamarneh; Charlotte A Jones; Brenda R Hemmelgarn
Journal:  J Am Coll Cardiol       Date:  2016-04-04       Impact factor: 24.094

6.  Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).

Authors:  Ross T Tsuyuki; Sherilyn K D Houle; Theresa L Charrois; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norm R C Campbell; Dale Cooney; Finlay A McAlister
Journal:  Circulation       Date:  2015-06-10       Impact factor: 29.690

Review 7.  Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Authors:  Valérie Santschi; Arnaud Chiolero; Bernard Burnand; April L Colosimo; Gilles Paradis
Journal:  Arch Intern Med       Date:  2011-09-12

Review 8.  Pharmacist prescribing: A scoping review about the views and experiences of patients and the public.

Authors:  Ida-Maisie Famiyeh; Lisa McCarthy
Journal:  Res Social Adm Pharm       Date:  2016-01-18

9.  A patient perspective of pharmacist prescribing: 'crossing the specialisms-crossing the illnesses'.

Authors:  Laura M McCann; Sharon L Haughey; Carole Parsons; Fran Lloyd; Grainne Crealey; Gerard J Gormley; Carmel M Hughes
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

10.  Pharmacist intervention for glycaemic control in the community (the RxING study).

Authors:  Yazid N Al Hamarneh; Theresa Charrois; Richard Lewanczuk; Ross T Tsuyuki
Journal:  BMJ Open       Date:  2013-09-24       Impact factor: 2.692
View more
  8 in total

1.  A leadership crisis in pharmacy.

Authors:  Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2018-12-12

2.  Why pharmacist prescribing needs to be independent.

Authors:  Ross T Tsuyuki; Kaitlyn E Watson
Journal:  Can Pharm J (Ott)       Date:  2020-02-13

3.  Patient-oriented pharmacy practice research: Why should we care?

Authors:  Yazid N Al Hamarneh; Zahava Rosenberg-Yunger; Arti Saxena; Nancy M Waite; Lisa Dolovich; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2020-03-19

4.  Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study.

Authors:  Yazid N Al Hamarneh; Karissa Johnston; Carlo A Marra; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2019-06-10

Review 5.  Barriers to a full scope of pharmacy practice in primary care: A systematic review of pharmacists' access to laboratory testing.

Authors:  Jacqueline Donovan; Ross T Tsuyuki; Yazid N Al Hamarneh; Beata Bajorek
Journal:  Can Pharm J (Ott)       Date:  2019-08-06

6.  RxIALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre-post intervention study.

Authors:  Yazid N Al Hamarneh; Carlo Marra; Robert Gniadecki; Stephanie Keeling; Andrea Morgan; Ross Tsuyuki
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

7.  Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia.

Authors:  Jordan Lewis; Arden R Barry; Katie Bellefeuille; Robert T Pammett
Journal:  Pharmacy (Basel)       Date:  2021-04-23

8.  Feasibility of cardiovascular risk screening in Portuguese community pharmacies.

Authors:  Anabela A Fonseca; Tácio M Lima; Margarida Castel-Branco; Isabel V Figueiredo
Journal:  Pharm Pract (Granada)       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.